03/07/2025
4:25 PM | Aurinia Pharmaceuticals (Issuer)
Keenan Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:57 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:58 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:59 PM | Aurinia Pharmaceuticals (Issuer)
Keenan Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:02 PM | Aurinia Pharmaceuticals (Issuer)
Greenleaf Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:56 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:05 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
5:12 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
4:05 PM | ARMISTICE CAPITAL, LLC (Filed by)
Aurinia Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/09/2024
3:52 PM | Aurinia Pharmaceuticals (Issuer)
TANG KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:38 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AUPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/25/2024
3:28 PM | Aurinia Pharmaceuticals (Issuer)
Jayne David R.W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
5:57 PM | Aurinia Pharmaceuticals (Issuer)
Johnson Craig A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/12/2024
6:05 PM | Aurinia Pharmaceuticals (Issuer)
Keenan Greg (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/12/2024
6:20 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
6:29 PM | Aurinia Pharmaceuticals (Issuer)
Bailey Jeffrey Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:17 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
5:13 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:56 PM | Aurinia Pharmaceuticals (Issuer)
MacKay-Dunn R. Hector (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:08 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
3:10 PM | Aurinia Pharmaceuticals (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
08/01/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
4:25 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:25 PM | Aurinia Pharmaceuticals (Filer)
| Form DEFA14A | |
05/22/2024
3:14 PM | Aurinia Pharmaceuticals (Issuer)
Billen Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:16 PM | Aurinia Pharmaceuticals (Issuer)
Balakrishnan Brinda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
4:23 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
